Inspire Medical Systems
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell INSP and other ETFs, options, and stocks.About INSP
Inspire Medical Systems, Inc. is a medical technology company, which focuses on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. The firm offers inspire therapy, which consists of a remote control and implantable components that includes pressure sensing lead, a neurostimulator, and a stimulation lead.
CEOTimothy P. Herbert
CEOTimothy P. Herbert
Employees1,246
Employees1,246
HeadquartersGolden Valley, Minnesota
HeadquartersGolden Valley, Minnesota
Founded2007
Founded2007
Employees1,246
Employees1,246
INSP Key Statistics
Market cap2.77B
Market cap2.77B
Price-Earnings ratio54.28
Price-Earnings ratio54.28
Dividend yield—
Dividend yield—
Average volume878.76K
Average volume878.76K
High today$94.58
High today$94.58
Low today$90.56
Low today$90.56
Open price$90.56
Open price$90.56
Volume635.04K
Volume635.04K
52 Week high$225.00
52 Week high$225.00
52 Week low$73.92
52 Week low$73.92
INSP News
TipRanks 5d
Inspire Medical Systems CFO to Step DownElevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...
Seeking Alpha 5d
Inspire Medical Systems CFO departsHealthcare Inspire Medical Systems CFO departs Aug. 26, 2025 4:36 PM ET Inspire Medical Systems, Inc. (INSP) Stock By: Akanksha Khushi, SA News Editor 5 Share...
Simply Wall St 6d
Why Inspire Medical Systems Is Up 8.7% After Unveiling $200 Million Share Buyback ProgramInspire Medical Systems recently announced a share repurchase program of up to US$200 million of its common shares through August 2027, subject to early termina...
Analyst ratings
52%
of 21 ratingsBuy
52.4%
Hold
47.6%
Sell
0%
People also own
Based on the portfolios of people who own INSP. This list is generated using Robinhood data, and it’s not a recommendation.